| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jan 25 | MRK Merck & Co. | Common Stock | Grant | Acquire A | No | No | 97.94 | 32,621 | 3.19 mm | 79,592.15 |
| 2 Jan 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,647 | 0.00 | 77,350 |
| 1 Oct 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,925 | 0.00 | 75,703 |
| 1 Jul 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,592 | 0.00 | 73,778 |
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 13,097 | 0.00 | 72,186 |
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 8.59 | 26,193 | 225.00 k | 26,193 |
